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Autism spectrum disorder (ASD) is characterized by impairments in both social
communication and interaction and repetitive or stereotyped behaviors. Although its
etiology remains unknown, genetic and environmental risk factors have been associated
with this disorder, including the exposure to valproic acid (VPA) during pregnancy.
Resveratrol (RSV) is an anti-inflammatory and antioxidant molecule known to prevent
social impairments in the VPA animal model of autism. This study aimed to analyze
the effects of prenatal exposure to VPA, as well as possible preventive effects of
RSV, on sensory behavior, the localization of GABAergic parvalbumin (PV+) neurons
in sensory brain regions and the expression of proteins of excitatory and inhibitory
synapses. Pregnant rats were treated daily with RSV (3.6 mg/kg) from E6.5 to
E18.5 and injected with VPA (600 mg/kg) in the E12.5. Male pups were analyzed
in Nest Seeking (NS) behavior and in whisker nuisance task (WNT). At P30, the
tissues were removed and analyzed by immunofluorescence and western blotting.
Our data showed for the first time an altered localization of PV+-neurons in primary
sensory cortex and amygdala. We also showed a reduced level of gephyrin in
the primary somatosensory area (PSSA) of VPA animals. The treatment with RSV
prevented all the aforementioned alterations triggered by VPA. Our data shed light
on the relevance of sensory component in ASD and highlights the interplay between
RSV and VPA animal model as an important tool to investigate the pathophysiology
of ASD.
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INTRODUCTION
Autism spectrum disorder (ASD) is a highly prevalent
neurodevelopmental condition affecting 1 in 68 children
aged 8 years in the USA (American Psychiatry Association
(APA), 2013) and is characterized, according to the DSM-5, by a
behavioral dyad composed by impairments in communication
and social interaction and repetitive or stereotyped behaviors
(American Psychiatry Association (APA), 2013). Although many
interesting theories have been recently proposed (Patterson,
2009; Lucchina and Depino, 2013; Sandin et al., 2014; Gottfried
et al., 2015), the ASD etiology remains unknown. This in turn
hinders the discovery of new biomarkers and treatments, making
ASD a significant individual and societal challenge (Bambini-
Junior et al., 2014a; Anderson, 2015; Hu et al., 2017; Masi et al.,
2017).
Autism has a high genetic heritability, which can be
demonstrated by the high agreement of ASD development in
monozygotic twins (reaching values of up to 90%; Dietert et al.,
2011), compared to a concordance rate of about 10% in dizygotic
twins (Miles, 2011; Yoo, 2015). In addition, some environmental
factors are also associated to ASD, including prenatal exposure
to valproic acid (VPA; Rodier et al., 1997; Christensen et al.,
2013; Smith and Brown, 2014). Thus, based on these clinical
observations, an animal model of autism by prenatal exposure
to VPA was developed. Since then, it has been extensively
validated, demonstrating a myriad of behavioral (Schneider and
Przewłocki, 2005; Haddad et al., 2009; Dendrinos et al., 2011;
Favre et al., 2013; Gottfried et al., 2013; Roullet et al., 2013;
Mabunga et al., 2015), molecular (Roullet et al., 2010; Gottfried
et al., 2013), morphological (Rodier et al., 1997; Dendrinos
et al., 2011; Favre et al., 2013; Gottfried et al., 2013) and
electrophysiological autistic-like features (Dawson et al., 2005;
Markram et al., 2008; Rinaldi et al., 2008).
Sensory impairments are one of the most prevalent
comorbidities associated with ASD and are identified in
more than 90% of patients (Geschwind, 2009). Indeed, hyper-
or hyporeactivity to sensory input have been used as one of
the four behavioral patterns observed to evaluate restricted,
repetitive patterns of behavior, interests, or activities in ASD
(American Psychiatry Association (APA), 2013). Common
deficits include hyper-responsiveness to non-harmful stimuli
(e. g., visual, tactile and auditory) and hypo-responsiveness to
harmful (nociceptive) stimuli (American Psychiatry Association
(APA), 2013). Studies investigating how sensory stimuli are
processed and integrated in patients with ASD and animal
models of autism are scarce. Yet, the impairments in the
perception of the environment possibly affect both social and
repetitive behaviors (Nienborg and Cumming, 2010; Dendrinos
et al., 2011; Wöhr et al., 2015) and the sensory deficits can also
be valuable for diagnostic purposes (Marco et al., 2011). The
prompted Ayres proposed a Sensory integration (SI) theory
to explain ASD and other neurological disorders (Cummins,
1991). Actually, previous studies showed correlations between
sensory misprocessing in cortical and subcortical regions with
altered excitatory/inhibitory balance and disorganization of
cortical columnar and laminar pattern in autistic individuals
(Spence and Schneider, 2009; Stoner et al., 2014; Khan et al.,
2015).
Given the abnormal sensory behaviors present in the
animal model of autism induced by VPA, we asked if the
neuronal organization in the primary somatosensory area
(PSSA) was affected by exposure to VPA. Interneurons have
a major role in brain circuits and organization, acting as
either switches or pattern generators and providing refinement
to the countless connections present in the brain (Xu
et al., 2010; Chu and Anderson, 2015). GABAergic neurons
expressing parvalbumin (PV+-neurons) are the most common
interneurons in the cortex, comprising 40% of the total
interneuron population (Staiger et al., 2009; Xu et al., 2010;
Rudy et al., 2011) and playing important roles in social
memory, attention, integration of different sensory areas
(Gogolla et al., 2009; Unichenko et al., 2017) and notably
providing a relevancy filter in sensory processing (Yang et al.,
2017). Therefore, we addressed the question of whether the
PV+-neuron distribution was altered in somatosensory cortex
and amygdala in the VPA model and if there was a concomitant
change in inhibitory and excitatory synaptic markers in this
region.
We recently showed that prenatal treatment with resveratrol
(RSV), a polyphenol compound presenting antioxidant and
anti-inflammatory properties, prevents altered social behavior in
the VPA animal model of autism (Bambini-Junior et al., 2014b).
Considering that the social impairments of the VPA animals
could be explained, at least partially, by excitatory/inhibitory
imbalance in the sensory cortices and amygdala, we asked if RSV
could prevent these alterations.
MATERIALS AND METHODS
Animals
Wistar rats were obtained from Center of Reproduction
and Experimentation of Laboratory Animals (CREAL) and
maintained under a standard 12/12-h light/dark cycle (light
cycle starting at 7 am and ending at 7 pm) at a constant
temperature of 22 ± 1◦C. The animals had ad libitum access
to food and water, and were handled in accordance with the
guidelines established by the National Council for the Control of
Animal Experimentation (CONCEA) of Brazil. This project was
approved by the ethics committee of the Federal University of
Rio Grande do Sul (CEUA-UFRGS #31872) and by the Clinical
Hospital of Porto Alegre (HCPA-FIPE #160477).
Animals were mated overnight and pregnancy was verified
by next morning through presence of spermatozoa in the
vaginal smear. This was considered the embryonic day
0.5 (E0.5). Pregnant rats were divided into four groups
according to the treatment they received: Control, RSV,
VPA, or RSV+VPA. From E6.5 to E18.5, the pregnant
females received a daily subcutaneously injection of RSV
(Fluxome, Stenløse, Denmark) at 3.6 mg/kg or dimethyl
sulfoxide (DMSO, equivalent volume of RSV injection) as
previously described (Bambini-Junior et al., 2014b). On E12.5,
rats received a single intraperitoneal injection with either
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VPA at 600 mg/kg (Acros Organics, NJ, USA) or saline
solution 0.9%.
Behavioral Tasks
Nest Seeking Behavior
We assessed the nest-seeking (NS) response mediated by
olfactory discrimination as described previously (Schneider and
Przewłocki, 2005) at the postnatal day 10 (P10). All litter
(males and females) was evaluated, since sex is very difficult
to determine during behavioral tests before P10 and one
would have to manipulate the litter, which could introduce a
stress component. The apparatus used was a plastic container
(30 × 20 × 13 cm) that was divided in thirds and had the
lateral sections covered with wood shavings, but leaving a clear
uncovered center. One side is filled with the home-cage bedding
(nest shavings) and in the other side with sterilized shavings. The
pup was placed in the center of the apparatus and the latency
to reach the nest shavings and the time to make any choice
was registered. The total time of the test was limited to 60 s.
In order to maintain the smell of the litter/mother, we did not
change the shavings in the home-cage in the 2 days preceding the
test.
Whisker Nuisance Task (WNT)
During this test, the animal behavioral response to direct
vibrissae stimulation was observed in P30 animals. All tests
and analyses were performed blindly. Since this is a sensory
test, prior to testing, animals were familiarized with handling
of the experimenter and habituated with the empty housing
(57.1 × 39.4 × 15.2 cm) coated with an absorbent pad. To
perform the test, the vibrissae are stimulated with a wooden
toothpick for three consecutive periods of 5 min (15 min in total)
with a 30 s interval between stimulation (Figures 1E,F). Animals
were scored according to a scale developed by McNamara et al.
(2010), in which freezing, stance and body position, breathing,
whisker position, whisking response, evading stimulation,
response to stick presentation and grooming are classified
from 0 to 2 according to the response (0 = absent/typical,
1 = present/light response and 2 = profound/accentuated
response; Supplementary Table S1). The sum of all scores is then
calculated. Low scores (0–4) indicate normal responses, in which
the animal is calm or indifferent to stimulation. High scores
(8–16) indicate abnormal responses to stimulation, in which
the animal freezes, shakes, or is aggressive (McNamara et al.,
2010).
Tissue Preparation and Analysis
Transcardiac Perfusion
P30 male rats were anesthetized (75 mg/kg ketamine +10 mg/kg
xylazine) and subjected to transcardiac perfusion with
0.9%-NaCl solution followed by 1.5%-paraformaldehyde
and 4%-paraformaldehyde solutions before the removal
of the brain. The tissues were post-fixed for 4 h in a 4%-
paraformaldehyde solution and subsequently cryoprotected
by sequential immersion in 15% and 30%-sucrose solutions
in PBS (the tissue was kept in each solution until complete
submersion).
Immunofluorescence
Brains were embedded in Tissue-Tekr and kept in −80◦C
ultra-freezer until further processing. Coronal brain slices
(25 µm) were obtained in cryostat (Leica Microsystems
GmbH) and a rat brain atlas (Paxinos and Watson, 1997)
was utilized to identify sections containing the PSSA and
the amygdala. We obtained the slices both from PSSA and
amygdalar region according to the Paxinos rat atlas, using
the following markers: Bregma (anteroposterior): −3.48 mm,
interaural: 5.52 mm (Figure 62 from Paxinos rat atlas). After
the immunofluorescence protocol from these slices described
above, we delimited the regions as it follows: for PSSA we first
localized the CA2 hippocampal region. Then moved laterally
from this region until finding cortical border, where we can
find the barrel fields, a specific region for whisker sensory
processing. We localized the layer II/III and IV/V examining
the cytoarchitecture of neuronal composition positive to NeuN
labeling, as described in literature (Narayanan et al., 2017).
For amygdalar region, we first localized the external capsule,
a white matter region easily identified by DAPI staining.
Then, we moved dorsoventrally to the end of this white
matter region and, medially to this point, we identified lateral
amygdalar region. We consider the amygdalar region since the
histological contour of lateral amygdalar complex is difficult to
determine.
The immunostaining procedure was performed in the
following steps: (1) exposure to vapors of 4%-paraformaldehyde
(10 min); (2) three washes with PBS 0.1 M buffer (5 min
each); (3) permeabilization with PBS-Triton 0.1% (10 min);
(4) three washes with PBS 0.1 M buffer (5 min each); (5) antigen
retrieval suing citrate buffer at 60◦C (1 h); (6) two washes
with PBS-Triton 0.1% (5 min each); (7) blocking with BSA
5% in PBS-Triton 0.1% (1 h); (8) incubation with primary
antibodies—diluted to 1:500 in blocking solution—for 48 h at
4◦C; (9) five washes with PBS 0.1 M buffer (3 min each);
(10) incubation with both secondary antibodies anti-mouse and
anti-rabbit—diluted to 1:2000 in blocking solution) for 2 h at
room temperature; (11) five washes with PBS 0.1 M buffer (3 min
each); (12) incubation with DAPI solution (10 min); and (13) five
washes with PBS 0.1 M buffer (3 min each) followed by addition
of mounting medium with fluorshield and coverslip. The list of
antibodies used in this work is available in the Supplementary
Table S2.
Images were obtained with at least eight times per image
(dimension: 635.9 × 635.9 microns) in a confocal microscope
(Olympus FluoView FV1000 confocal laser scanning) of the
Electron Microscopy Core. Processing and quantification of
all tomes obtained from two to four tissue sections per glass
slide were performed using the ImageJ software with the Cell
Counter plug-in. The neuronal quantification results are shown
in absolute number of NeuN+ labeled cells (total neuronal
cells), PV+ and NeuN+ labeled cells (PV-neuronal cells) and
in density of PV+-neuronal cells (which is the ratio between
absolute number of PV+-neuronal cells by the total number of
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FIGURE 1 | Animals from the valproic acid (VPA) model of autism demonstrate impaired sensorial behavior, which is counteracted by resveratrol (RSV).
(A) Representative illustration from the Nest Seeking (NS) test. RSV administration could not prevent all behavioral alterations in VPA groups, which presented an
increasing time to reach the nest (B) and increased latency to make any choice (C). Whilst VPA induced significant decrease in the accuracy of the choice, prenatal
RSV treatment prevented this feature (D). (E,F) Representative illustration of the stimulation in the Whisker Nuisance Task (WNT; E) and possible position of whiskers:
protracted (curiosity), retracted (avoidance) or not showing any particular response (F). (G) Behavioral analysis of WNT, demonstrating the hyper-responsiveness of
VPA animals, a behavior prevent by RSV treatment. Different letters indicate statistically significant differences between groups. Values plotted are Mean ± standard
deviation (SD). Statistical analysis: ordinary one-way analysis of variance (ANOVA) followed by Bonferroni.
neuronal cells) for layer II/III, layer IV/V and all layers (II/III
and IV/V). The number of PV+-neurons, total neurons and
total cells were counted by an observer blind to the animal
group.
Eletrophoresis and Western Blotting
Amygdala region (AmR) and PSSA were surgically isolated
and fresh tissues homogenates were prepared in lysis
buffer. Protein concentration was measured by Lowry
method (Lowry et al., 1951), equal amounts of protein
(40 µg) were loaded in SDS-polyacrylamide gels and
transferred to nitrocellulose membranes. After overnight
incubation with the primary antibody at 4◦C (Anti-
PSD95, Anti-gephyrin, Anti-synaptophysin or Anti- β-
actin; Supplementary Table S3), membranes were incubated
with the proper secondary antibody conjugated to HRP
(Donkey anti-mouse-IgG HRP or Goat anti-rabbit-IgG
HRP) at room temperature for 1:30 h. No stripping of the
membranes was performed (Supplementary Figures S1, S2).
The SuperSignal West Pico reagent (Thermo Fisher Scientific)
was used and its chemiluminescence was detected using the
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FIGURE 2 | RSV prevents the impairments in cortical organization of the primary somatosensory area (PSSA) induced by VPA. (A–D) Cell nuclei—blue (DAPI) and
total neurons—red (NeuN+). Layers II-III and IV-V can be distinctly visualized by its specific cellularity, enabling a qualitative analysis of the cortical laminar
organization between the groups. Scale bar = 50 µm.
ImageQuant LAS 4000 immunodetector (GE HealthCare Life
Sciences).
Statistical Analysis
One-way analysis of variance (ANOVA) followed by
Bonferroni’s post hoc multi comparison test was performed
using the IBM SPSS software (version 20.0). Data are reported as
mean ± standard deviation (SD), considering significant when
p < 0.05. In graphic representation, different letters indicate
statistically significant differences between the experimental
groups. The total number of animals analyzed in each experiment
was four animals from at least four different litters per group.
RESULTS
In the Nest Seeking Behavior, RSV
Prevents the Reduction of Accuracy But
Not the Increase in Latency for Choice
Induced by VPA
In order to evaluate the effects of VPA and RSV on
olfactory discrimination, P10 pups were tested for NS behavior
(Figure 1A). The following parameters were evaluated: latency
to reach the nest shavings, latency to make any choice (nest
or sterile shavings) and percentage of correct choices (reach
the nest shavings) per litter. The latency to reach the nest
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FIGURE 3 | RSV averts the abnormal distribution of PV+ GABAergic neurons in the PSSA of animals of the VPA model of autism. Cell nuclei—blue (DAPI), total
neurons—red (NeuN+) and GABAergic parvalbumin (PV+) neurons—green. (A) Representative immunofluorescence images of PSSA. Layer II-III and IV-V are
separated in order to improve visualization of cell distribution. In each case, the first micrograph presents the green channel showing PV+ cells distribution in the
indicated groups, followed by the merge image of three channels below (green, red and blue). (Ba–i) Quantitative analysis of PV+ cells in layer II-III and IV-V. Different
letters indicate statistically significant differences between groups. Values plotted are Mean ± SD. Statistical analysis: ordinary one-way ANOVA followed by
Bonferroni. Scale bar = 50 µm.
shavings (Figure 1B) was increased in animals of the groups
VPA (p = 0.0063) and RSV+VPA (p = 0.0486) when compared
to the control group (Control: 17.1 ± 3.4, RSV: 17.4 ± 3.2,
VPA: 32.1 ± 13.4, RSV+VPA: 27.8 ± 7.0, F = 6.8). In a similar
way, the latency to make any choice (Figure 1C) was also
increased in VPA (p = 0.0116) and RSV+VPA (p = 0.0011)
groups compared to the control (Control: 14.8 ± 3.6, RSV:
12.2 ± 3.5, VPA: 27.2 ± 12.6, RSV+VPA: 29.8 ± 5.1, F = 13.05).
Thus, VPA delayed the general response time of the animals,
which was not prevented by RSV. There were no significant
differences between groups in latency to reach sterile shavings
and in the total time spent by the pups in either of the shavings
(data not shown). However, prenatal administration of RSV
successfully prevented the reduction of percentage of correct
choices (Figure 1D) seen in the VPA group (Control: 0.95± 0.05,
RSV: 0.8 ± 0.16, VPA: 0.6 ± 0.22, RSV+VPA: 0.89 ± 0.08,
F = 5.9; p = 0.0020, VPA vs. Control and p = 0.0252, VPA vs.
RSV+VPA).
RSV Prevents the Abnormal Response to
Direct Whisker Stimulation Observed in
Rats of the VPA Model of Autism
Since ASD is usually associated with several impairments in SI,
we sought to investigate the behavioral response of rats of the
VPA model of autism in the Whisker Nuisance Task (WNT;
Figure 1E). Animals from the VPA group increased WNT scores
(Figure 1G) as compared to the control group (p = 0.0027, VPA
compared to the control group). Strikingly, prenatal treatment
with RSV averted the over-responsiveness induced by VPA
(Control: 4.2± 1.1, RSV: 3.6± 0.72, VPA: 6.8± 1.2, RSV+VPA:
4.2± 0.42, F = 12.4; p = 0.0006, VPA vs. RSV+VPA group).
RSV Counteracts the VPA Effects on
Neuronal Organization in the Primary
Somatosensory Cortex, Promoting Typical
Laminar Distribution and Localization of
PV+-Neurons
As shown in Figures 2A,B, the control and RSV groups
presented a typical cortical organization, with a high number
of medium-sized pyramidal neurons in layer II-III and
granular and largest pyramidal neurons in layer IV-V, and
a low cellularity between these layers. However, the VPA
exposure induced visible alterations in cellular organization,
increasing the space between layer I and layer II-III while
drastically reducing the spacing between layer II-III and layer
IV-V (Figure 2C). Interestingly, prenatal RSV treatment was
able to prevent the VPA effects on cortical organization
(Figure 2D).
We then asked if there was any change in the number of
PV+- neurons in layer II-III and layer IV-V of the PSSA.
Representative micrographs of the layer II-III (a–d) and layer
IV-V (e–h) are shown in Figure 3A. Our quantitative analysis
revealed a significant increase in number of PV+ neurons
in layer II-III of the VPA group, when compared to control
animals (p = 0.0029). In addition, as showed in Figure 3Ba,
RSV treatment successfully prevented this alteration (Control:
25.7 ± 5.5, RSV: 26.2 ± 8.3, VPA: 49 ± 7.8, RSV+VPA:
27.3 ± 2.5, F = 11.1; p = 0.0087, VPA compared to RSV+VPA
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group). On the other hand, animals of the VPA group
showed reduced numbers (p = 0.0180) of PV+-neurons in
layer IV-V, as compared to the control group (Figure 3Bb).
Interestingly, RSV was also able to prevent this change (Control:
36.2 ± 6.3, RSV: 40.7 ± 4.2, VPA: 23.3 ± 3.3, RSV+VPA:
38.3 ± 5.03, F = 10.2; p = 0.0110, VPA compared to the
RSV+VPA group). No significant differences were found in
the sum of PV+-neurons of all cortical layers, suggesting an
impairment of neuron localization rather than overall quantity
(Figure 3Bc).
We also evaluated the total number of neurons in layer II-III
and layer IV-V of PSSA using immunostaining with the NeuN
marker. Our results pointed out for an effect of RSV exposure
(p = 0.0328), increasing the total number of neurons in layer II-III
(Figures 3Bd–f), in comparison to the control group (Control:
274.3 ± 21.8, RSV: 410.5 ± 91.9, VPA: 296.3 ± 47.5, RSV+VPA:
350± 19.9, F = 4.7).
When normalizing the number of PV+-neurons to the total
number of neurons, the VPA group presented a significantly
increased ratio in layer II/III (p < 0.0001), which was prevented
by RSV (p < 0.0001, VPA compared to the RSV+VPA
group). Surprisingly, the RSV treatment per se reduced the
ratio PV+-neurons/total neurons (Figure 3Bg; p = 0.0356)
in this same region when compared to control (Control:
0.09319 ± 0.01211, RSV: 0.063 ± 0.01, VPA: 0.16 ± 0.016,
RSV+VPA: 0.07 ± 0.003, F = 52.4). We also observed a
significant decrease in the PV+-neurons/total neurons ratio
in the VPA group compared to controls (Figure 3Bh;
p = 0.0023). Importantly, this alteration was also prevented by
RSV (Control: 0.11 ± 0.02, RSV: 0.11 ± 0.01, VPA: 0.06 ± 0.01,
RSV+VPA: 0.1 ± 0.007, F = 9.8; p = 0.0290 to VPA vs.
RSV+VPA). When combining all layers, we only observed an
effect of RSV (Figure 3Bi), reducing the PV+-neurons/total
neurons ratio (Control: 0.10 ± 0.007, RSV: 0.08 ± 0.004,
VPA: 0.11 ± 0.014, RSV+VPA: 0.09 ± 0.002, F = 7.5;
p = 0.0438). Thus, our immunofluorescence data suggests a
protective effect of RSV for the laminar organization and correct
distribution of PV+-neurons in animals of the VPA model of
autism.
RSV Reestablishes a Typical Proportion of
PV+-Neurons in the Amygdala
Given the importance of the AmR to attribute affective content
to sensory information, we also evaluated the quantity of
PV+-neurons in this region. Figures 4Aa–d shows illustrative
micrographs from PV+-neuron distribution in the amygdala
of our four experimental groups. As showed in Figure 4Ba,
no significant differences were observed in the number of
PV+-cells (Control: 33.8 ± 6.6, RSV: 25.6 ± 7.5, VPA:
24.2 ± 8.5, RSV+VPA: 32.1 ± 3.5, p = 26, F = 1.55) or
(Figure 4Bb) in the total number of neuronal cells (Control:
221.8 ± 71.6, RSV: 413 ± 17.5, VPA: 402.6 ± 97.9, RSV+VPA:
277.3 ± 46.3, p = 0.2119, F = 1.79). Nevertheless, we
observed a significant reduction in the PV+-neurons/total
neurons ratio (Figure 4Bc) in the RSV (p = 0.0040) and
VPA groups (p = 0.0015), when compared to the control
FIGURE 4 | RSV restores the correct proportion of PV+ neurons in the
amygdala of rats of the animal model of autism induced by VPA. Cell
nuclei—blue (DAPI), total neurons—red (NeuN+) and GABAergic PV+
neurons—green (PV+). (Aa–d) Representative immunofluorescence images of
the amygdala Region (AmR). Cell distribution and organization can be
visualized along the basolateral portion of AmR. (Ba–c) Quantitative analysis
of the density of PV+ neurons in the AmR. Different letters indicate statistically
significant differences between groups. Mean ± SD were represented.
Statistical analysis: ordinary one-way ANOVA followed by Bonferroni. Scale
bar = 50 µm.
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FIGURE 5 | Effects of prenatal exposure to VPA and RSV in synaptic proteins in PSSA and AmR. Representative images of Western blotting for synaptic proteins are
shown in (Aa) from PSSA and in (Ba) from AmR. Protein quantification of gephyrin, PSD-95 and synaptophysin are shown in (Ab–d) for PSSA and in (Bb–d) for
AmR, respectively. Different letters indicate statistically significant differences between groups. Mean ± SD were plotted. Statistical analysis: ordinary One-Way
ANOVA followed by Bonferroni.
group. Interestingly, RSV was able to totally prevent the
VPA effect (Control: 0.16 ± 0.04, RSV: 0.06 ± 0.017, VPA:
0.059 ± 0.016, RSV+VPA: 0.12 ± 0.02, F = 12.09). Here,
our results demonstrate interesting and complex effects of
RSV and VPA exposures in the AmR in which the combined
actions of VPA and RSV normalized the PV+/total neurons
ratio.
VPA and RSV Modulate Synaptic Proteins
in Primary Somatosensory Area (PSSA)
and Amygdala Region (AmR)
Next, we asked if the neuronal reorganization promoted by
VPA and prevented by RSV in PSSA and AmR influenced the
overall expression of synaptic proteins. We evaluated proteins
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from excitatory (PSD-95) and inhibitory (gephyrin) synapses, as
well as synaptophysin, an ubiquitous pre-synaptic component.
Illustrative western blot images are shown in Figure 5Aa (PSSA)
and Figure 5Ba for (AmR). No significant differences were
observed between groups in PSD-95 levels in PSSA (Figure 5Ac)
or AmR (Figure 5Bc). On the other hand, gephyrin levels
were reduced in the PSSA of VPA animals compared to the
control group (Control: 5.306 × 107 ± 3.123 × 106, RSV:
3.959 × 107 ± 1.426 × 107, VPA: 2.859 × 107 ± 9.937 × 107,
RSV+VPA: 4.020 × 107 ± 1.188 × 107, F = 3.54; p = 0.0305).
In the PSSA of RSV+VPA animals, gephyrin is expressed
at intermediate levels between the control and VPA groups,
not being statistically different from either one (Figure 5Ab).
No significant differences were observed in the expression of
gephyrin in the AmR of our experimental groups (Figure 5Bb).
The synaptophysin and PSD-95 expression levels are not
significantly different between groups in PSSA (Figure 5Ad) or
AmR (Figure 5Bd).
DISCUSSION
The response to sensory stimuli is altered in more than 90%
of ASD patients resulting in great impairment in synaptic
transmission and processing, affecting the health of these
individuals (Coskun et al., 2009; Geschwind, 2009). These
alterations include hyper-responsiveness to auditory, visual
and tactile stimuli and hypo responsiveness to nociceptive
stimuli. An interesting hypothesis suggests a perturbation in the
processing and integration of the sensory information between
different areas, resulting in local and global alterations, from
neurotransmitter release, to the neural network, leading to
disruption of sensory perception (Coskun et al., 2013; Supekar
et al., 2013). Here we report, for the first time, that RSV prevented
the alterations caused by VPA in the WNT, a behavioral test that
evaluates quality of response to direct whisker stimulation. In
addition to the striking result in the present work, RSV was able
to preserve the cortical laminar patterning and the distribution
of PV+-neurons affected by VPA in the PSSA, the brain area
related to tactile processing of the whiskers (Chen-Bee et al.,
2012). These results corroborate similar findings in the literature
in other brain regions involved in sensory processing, such as the
superior colliculus, presenting dysfunctional sensory processing
characterized by an inability to filter sensory information and
impairments in GABAergic synaptic transmission, particularly
simultaneously arriving multimodal inputs (Dendrinos et al.,
2011).
The behavior evaluated in the NS test is of extreme
importance for the development of rats, which need major
care from their mothers to survive. This attachment behavior
is present in many species (Broad et al., 2006) and combines
a sensory component (olfactory, in rodents) with an affective
memory, creating a mother-offspring connection that allows
young animals (who can barely see or hear at this age) to find
the source of food and protection. The AmR is an important
area for primary attachment behaviors and other emotional
responses, such as aversive behavior (Landers and Sullivan,
2012; Rigon et al., 2016). In the context of ASD, it is known
that many alterations were already described in the amygdala,
including hyper reactivity (Markram et al., 2008; Lin et al.,
2013), enlargement and hyper cellularity (Markram et al., 2008;
Ecker et al., 2015), elevated NMDA receptor levels and enhanced
postsynaptic long-term potentiation (LTP; Rinaldi et al., 2007).
Therefore, our hypothesis highlights the possibility that an
alteration in this region is causing the impairment identified
in the NS task and can be related to the outcomes in social
development. Interestingly, studies have demonstrated that the
AmR seems to develop faster in animals of the VPA model of
autism. It results in premature maturation of fear responses,
caused by the hyper reactivity, hyper plasticity and deficits in
inhibitory system found in the lateral amygdala, which could
lead to an early termination of the attachment learning period
(Markram et al., 2008; Landers and Sullivan, 2012; Barrett et al.,
2017).
We report in our present work that RSV reestablishes the
typical proportion of GABAergic PV+-neurons in the amygdala
of VPA animals, which might be crucial for proper inhibition
of responses in the amygdala (McDonald and Betette, 2001;
Woodruff and Sah, 2007; Bocchio et al., 2015). The majority
of PV+-neurons originate in the medial ganglionic eminence
and migrate to their target regions in the brain (Guo and
Anton, 2014). The ganglionic eminence is a temporary brain
structure first observed at E11.5 in rodents (Lavdas et al.,
1999; Anderson et al., 2001; Marín et al., 2001) with the first
interneurons starting their tangential migration towards the
cortex at E12.5 in mice (Kelsom and Lu, 2013). This coincides
with our hypothesis of the time point of VPA administration and
opens the intriguing possibility that VPA interferes either with
GABAergic interneuron specification and proliferation or their
migration to the cortical layers and their survival in the cortex,
promoting the increase of PV+-neuronal density in layer II/III
and the decrease of this subpopulation in layer IV/V. In fact,
studies with 7 days old mice of the VPA model of autism present
a reduced number of BrdU+ cells (generated at E12.5) in the deep
layers of the somatosensory and prefrontal cortices, indicating
several impairments in cortical migration related to cortical areas
(Kataoka et al., 2013).
A decreased number of PV+-neurons and of PV mRNA was
observed in several animal models related to ASD (Gogolla et al.,
2009; Wöhr et al., 2015; Lauber et al., 2016) and a recent study
demonstrated reduction in the number of PV+-neuros in the
medial prefrontal cortex of individuals with autism (Hashemi
et al., 2017). Even though the significance of the reduction
of PV+-neurons in ASD remains unclear, PV knockout mice
display behavioral phenotypes related to all the core symptoms
present in ASD patients, such as abnormal reciprocal social
interactions, altered ultrasonic vocalization and presence of
repetitive/stereotyped patterns of behavior (Wöhr et al., 2015).
Moreover, there is an increase of apoptosis in the developing
neocortex 12 h and 24 h after VPA exposure, accompanied by a
reduction in proliferation in the ganglionic eminences (Kataoka
et al., 2013). This can likely have widespread and long-lasting
consequences to brain organization, since, during development,
GABAergic neurons are excitatory and promote the maturation
of neural networks (Le Magueresse and Monyer, 2013).
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Finally, in western blotting analysis, we observed in this work
a significant alteration in the expression level of the protein
gephyrin (a key scaffolding protein of inhibitory synapses) in
PSSA: VPA decreased its levels and RSV treatment was able to
prevent this impairment. These findings corroborate previous
studies showing an excitatory/inhibitory imbalance in cortical
regions of animal models of ASD (Rinaldi et al., 2008; Gao
and Penzes, 2015; Nelson and Valakh, 2015). Since, VPA affects
the PV+-neuron localization and distribution, this might lead
to altered inhibitory synaptic distribution and organization,
as seen in autistic individuals (Zikopoulos and Barbas, 2013;
Gao and Penzes, 2015; Nelson and Valakh, 2015). Thus, the
RSV prevention could be related to the excitation/inhibition
balance restoration in the PSSA, leading to correct sensory
perception/processing.
It is also possible that both RSV and VPA primarily
exert independent actions in the developing nervous system,
modulating neuronal proliferation, migration and establishment
of synaptic connections. It is worth to mention that RSV is itself,
a teratogen. Therefore, we are not proposing this approach as
a ‘‘vaccine’’ to ASD but as a potential research tool, that could
help to clarify specific mechanisms related to ASD etiology and
pathophysiology.
Our results from behavioral, histological and protein analyses
showed a relevant impact of RSV treatment in sensory aspects
of the VPA animal model of autism. Thus, RSV can be used
as a tool to study pathways related to ASD pathophysiology,
and further investigation of VPA effects counteracted by RSV
can help to shed light in molecular mechanisms involved in the
etiology of ASD.
CONCLUDING REMARKS
Taken together, our data showed important deficits in the
processing and integration of sensory information in the
VPA animal model of autism, corroborating the face validity
of this model. Furthermore, the prenatal treatment of RSV
successfully prevented sensory deficits in behavioral analyses,
possibly by correcting altered PV+-neuron localization and
cortical organization impaired by VPA.
We suggest that not only the correct number, but also
localization of PV+-neurons throughout the PSSA cortical layers,
might play important roles in proper sensory processing, refining
the excitatory inputs. Additionally, in AmR, the correct balance
of this neuronal subpopulation might be necessary to attribute
the correct emotional load to sensory information, providing a
refined and complex cognitive experience. Thus, the perturbation
of PV by VPA may be an important player in the sensory
behavioral deficits evaluated.
Since RSV appears as a promising molecule for investigation
of ASD etiology and pathophysiology, it is important to
explore whether these effects result from its anti-inflammatory
or anti-oxidant properties or from previously unrecognized
activities of this compound. Furthermore, it will be of upmost
importance to investigate the opposite actions of VPA and RSV
during embryonic development and in the pregnant female to
characterize the molecular alterations involved in the triggering
of autistic-like alterations in the VPA animal model of autism.
Again, we think that our data support the possible therapeutic
use of RSV, but future studies have to be done to show if RSV
has any beneficial effect on the postnatal development of animals
presenting autistic-like features.
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